A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
- Status
- RECRUITING
- Phase
- PHASE2
Cancer Immunotherapeutic (PCI) Strategy in Triple Negative Breast Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01
- Status
- RECRUITING
- Phase
- PHASE2
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Amping up With PemJAK
- Status
- RECRUITING
- Phase
- PHASE2
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible for Standard Treatment
- Status
- RECRUITING
- Phase
- PHASE2
A Study of BL-M07D1 in Combination With Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic HER2-Overexpressing Non-Squamous NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
- Status
- RECRUITING
- Phase
- PHASE1
Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies
- Status
- RECRUITING
- Phase
- PHASE1
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2